EUR 32.66
(2.7%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 510.93 Million SEK | 43.3% |
2022 | 31.88 Million SEK | 22.62% |
2021 | 26 Million SEK | 0.96% |
2020 | 25.75 Million SEK | -8.28% |
2019 | 28.08 Million EUR | 10.11% |
2018 | 25.5 Million EUR | 18.85% |
2017 | 21.45 Million EUR | 15.08% |
2016 | 18.64 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 174.11 Million EUR | 24.96% |
2024 Q3 | 179.66 Million SEK | 3.81% |
2024 Q1 | 12.57 Million SEK | -10.57% |
2023 FY | 45.68 Million SEK | 43.3% |
2023 Q4 | 13.84 Million SEK | 23.25% |
2023 Q1 | 9.46 Million SEK | -4.45% |
2023 Q2 | 10.71 Million SEK | 13.31% |
2023 Q3 | 11.23 Million SEK | 4.83% |
2022 Q2 | 7.92 Million EUR | 7.1% |
2022 FY | 31.88 Million SEK | 22.62% |
2022 Q4 | 9.9 Million EUR | 14.86% |
2022 Q3 | 8.62 Million EUR | 8.8% |
2022 Q1 | 7.39 Million EUR | -3.54% |
2021 Q4 | 7.66 Million EUR | 0.0% |
2021 FY | 26 Million SEK | 0.96% |
2020 FY | 25.75 Million SEK | -8.28% |
2019 FY | 28.08 Million EUR | 10.11% |
2018 FY | 25.5 Million EUR | 18.85% |
2017 FY | 21.45 Million EUR | 15.08% |
2016 FY | 18.64 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 124.1 Million EUR | -311.688% |
Carl Zeiss Meditec AG | 878.62 Million EUR | 41.849% |
Fielmann Aktiengesellschaft | 289.86 Million EUR | -76.265% |
Gerresheimer AG | 383.92 Million EUR | -33.081% |
Sartorius Aktiengesellschaft | 1.02 Billion EUR | 50.1% |
Sartorius Aktiengesellschaft | 1.02 Billion EUR | 50.031% |